Medicare Enrolled
Dr. Michael Barkoukis, MD
Urology Physician · Cleveland, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barkoukis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barkoukis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barkoukis
Dr. Michael Barkoukis is an urology physician in Cleveland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barkoukis performed 5,971 Medicare services across 2,528 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barkoukis received a total of $9,283 from 58 pharmaceutical and/or device companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barkoukis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in OH
$9,283 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,971
Medicare services
Top 5% in OH for urology physician
2,528
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~299 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,177 | $2 | $5 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
787 | $3 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
503 | $83 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $53 | $117 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
254 | $47 | $201 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
253 | $8 | $16 |
| PSA test (prostate cancer screening) | 240 | $18 | $107 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
192 | $34 | $93 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
158 | $7 | $60 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
152 | $2 | $25 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 104 | $134 | $720 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
100 | $14 | $84 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
100 | $47 | $193 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
96 | $38 | $101 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $35 | $93 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
62 | $36 | $156 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
58 | $62 | $308 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $61 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $104 | $345 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $24 | $126 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
33 | $23 | $436 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
29 | $72 | $1,213 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
23 | $141 | $720 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
22 | $21 | $143 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $94 | $652 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $90 | $1,030 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
16 | $34 | $93 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
14 | $190 | $1,846 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $413 | $3,856 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $557 | $3,058 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
11 | $19 | $91 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
5.2% medium
94.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,283
Total received (2018-2024)
Avg $1,326/year across 7 years
Top 18% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
261
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,588 (60.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,695 (39.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$689
2023
$528
2022
$698
2021
$722
2020
$780
2019
$4,946
2018
$920
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABC Home Medical Supply, Inc.
$63
Astellas Pharma US Inc
$59
Boston Scientific Corporation
$57
Bayer Healthcare Pharmaceuticals Inc.
$49
Novartis Pharmaceuticals Corporation
$46
Blue Earth Diagnostics Limited
$38
ABBVIE INC.
$31
Dendreon Pharmaceuticals LLC
$28
Tempus AI, Inc
$25
Telix Pharmaceuticals
$24
BLUEWIND MEDICAL
$21
PROGENICS PHARMACEUTICALS, INC.
$21
Tolmar, Inc.
$21
PFIZER INC.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Medtronic, Inc.
$20
Sumitomo Pharma America, Inc.
$20
Myriad Genetic Laboratories, Inc.
$19
Laborie Medical Technologies Corp.
$18
UROGEN PHARMA, INC.
$16
Verity Pharmaceuticals Inc.
$16
Calyxo, Inc.
$15
Janssen Biotech, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Olympus America Inc.
$13
Top 3 companies account for 25.9% of 2024 payments
All-time payments by company (2018-2024) ›
Integra GPO, LLC
$3,695
Astellas Pharma US Inc
$1,198
NeoTract Inc.
$441
Janssen Biotech, Inc.
$393
Dendreon Pharmaceuticals LLC
$297
Endo Pharmaceuticals Inc.
$266
TOLMAR Pharmaceuticals, Inc.
$214
PFIZER INC.
$176
Myovant Sciences Inc.
$156
C. R. Bard, Inc. & Subsidiaries
$146
Avadel Specialty Pharmaceuticals, LLC
$128
UROGEN PHARMA, INC.
$116
Bayer HealthCare Pharmaceuticals Inc.
$112
Amgen Inc.
$112
Blue Earth Diagnostics Limited
$110
Medtronic USA, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$96
C. R. BARD, INC. & SUBSIDIARIES
$92
Teleflex LLC
$77
Verity Pharmaceuticals Inc.
$73
Allergan, Inc.
$72
Boston Scientific Corporation
$71
ABBVIE INC.
$70
Novartis Pharmaceuticals Corporation
$70
Coloplast Corp
$66
Antares Pharma, Inc.
$63
ABC Home Medical Supply, Inc.
$63
Progenics Pharmaceuticals, Inc.
$56
Sumitomo Pharma America, Inc.
$49
AbbVie, Inc.
$47
MEDIVATION FIELD SOLUTIONS LLC
$46
Axonics Modulation Technologies, Inc.
$33
UROVANT SCIENCES INC
$33
AbbVie Inc.
$29
Janssen Scientific Affairs, LLC
$29
Ferring Pharmaceuticals Inc.
$29
AstraZeneca Pharmaceuticals LP
$27
Axonics, Inc.
$26
Olympus America Inc.
$25
Clarus Therapeutics Inc.
$25
COLOPLAST CORP
$25
Tempus AI, Inc
$25
ACCORD HEALTHCARE, INC.
$24
Telix Pharmaceuticals
$24
BLUEWIND MEDICAL
$21
PROGENICS PHARMACEUTICALS, INC.
$21
Tolmar, Inc.
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Medtronic, Inc.
$20
Myriad Genetic Laboratories, Inc.
$19
Merck Sharp & Dohme LLC
$19
Laborie Medical Technologies Corp.
$18
Accord Healthcare, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
Calyxo, Inc.
$15
KOELIS Inc.
$15
Rochester Medical Corporation
$14
Photocure Inc
$13
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
AMS 700 · AVEED · Androgel · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSVIEW · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GEMTESA · GENESIS · Genesis · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · MAGIC3 · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · REVI · Rezum Generator · TITAN · Titan · Trelstar · Trinity · UROLIFT · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
78
Per 100K population
6.2
County median income
$62,823
Nearest hospital
SOUTHWEST GENERAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barkoukis is a clinical cardiology specialist, with above-average Medicare volume (top 5% in OH), with low-engagement industry engagement in the top 18% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barkoukis experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Barkoukis performed 2,177 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barkoukis receive payments from pharmaceutical companies?
Yes. Dr. Barkoukis received a total of $9,283 from 58 companies across 261 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barkoukis's costs compare to other urology physicians in Cleveland?
Dr. Barkoukis's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barkoukis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cleveland
Browse urology physicians in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Integra GPO, LLC Payments to Doctors
See all physicians who received payments from Integra GPO, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology